New hope for breast cancer when standard drugs stop working
NCT ID NCT03147287
Summary
This study is testing three different drug combinations for advanced breast cancer that has continued to grow despite prior hormone therapy and a specific type of targeted drug (a CDK4/6 inhibitor). It aims to see if continuing the targeted drug, possibly with an added immunotherapy drug, can help control the cancer longer than hormone therapy alone. The trial is for adults with ER-positive, HER2-negative metastatic breast cancer who previously benefited from the targeted drug for at least 6 months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aurora Cancer Care
Milwaukee, Wisconsin, 53215, United States
-
Baylor University
Houston, Texas, 77030, United States
-
Boston Medical Center
Boston, Massachusetts, 02188, United States
-
DF/BWCC at Milford Regional Medical Center
Milford, Massachusetts, 01757, United States
-
DF/BWCC in clinical affiliation with South Shore Hospital
South Weymouth, Massachusetts, 02190, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Dana-Farber at St. Elizabeth's Medical Center
Brighton, Massachusetts, 02135, United States
-
Dana-Farber/New Hampshire Oncology-Hematology
Londonderry, New Hampshire, 03053, United States
-
Eastern Maine Medical Center
Bangor, Maine, 04401, United States
-
Emory University - Winship Cancer Institute
Atlanta, Georgia, 30322, United States
-
Indiana University
Indianapolis, Indiana, 46202, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
The University of Kansas Cancer Center
Westwood, Kansas, 66205, United States
-
The University of Kansas Cancer Center - Lee's Summit
Lee's Summit, Missouri, 64064, United States
-
The University of Kansas Cancer Center - North
Kansas City, Kansas, 64154, United States
-
The University of Kansas Cancer Center - Overland Park
Overland Park, Kansas, 66210, United States
-
University of Louisville
Louisville, Kentucky, 40202, United States
-
University of Miami
Miami, Florida, 33136, United States
-
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
-
Washington University
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.